ClinVar Miner

Submissions for variant NM_000053.4(ATP7B):c.994G>T (p.Glu332Ter) (rs761084829)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000668824 SCV000793489 pathogenic Wilson disease 2017-08-24 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000668824 SCV000914630 pathogenic Wilson disease 2018-08-15 criteria provided, single submitter clinical testing The ATP7B c.994G>T (p.Glu332Ter) variant is a stop-gained variant predicted to result in the premature termination of the protein. The p.Glu332Ter variant has been reported in four studies in which it was found in a compound heterozygous state with a missense variant in two individuals diagnosed with Wilson disease (WND) (Geng et al. 2013; Yu et al. 2017) and in at least nine additional affected individuals whose genotype information was not provided and in whom the zygosity of the variant is unknown (Li et al. 2011; Dong et al. 2016). All of the individuals carrying the variant were of Chinese ethnicity. One of the individuals carrying the variant in a compound heterozygous state was diagnosed with the osseomuscular type of WND (Yu et al. 2017). The p.Glu332Ter variant was absent from 100 controls and is not found in the 1000 Genomes Project, Exome Sequencing Project, Exome Aggregation Consortium, or Genome Aggregation Database, in a region of good sequence coverage, so is presumed to be rare. Overexpression followed by immunofluoresence studies of myc-tagged variant protein in both CHO and SH-SY5Y cells, demonstrated that the variant resulted in a mislocalisation, showing a diffuse and homogenous distribution in the cytosol, compared to the wild type protein shown to be located in the Golgi apparatus (Zhu et al. 2013). Based on the collective evidence and potential impact of stop-gained variants, the p.Glu332Ter variant is classified as pathogenic for Wilson disease. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.